Table 2.

Association with p < 10⁻⁴ for GE and BMI-GE analyses. Results highlighted in green or red in Figures 1 and 3. More detailed summaries of these top hits are shown in Supplemental Tables 4 and 5.

Analysis	Histology	Environment	Gene	SNP	MAF	N cases	N controls	Interaction	P-value
GE	All	EPP MHT	IGF1R	rs41497346	0.28	2870	5051	−0.577	4.92 × 10−6
GE	All	Endometriosis	ESR1	rs12661437	0.34	5335	9306	0.534	1.47 × 10−5
GE	ENDO	Estrogen MHT	HSD17B2	rs2955162	0.23	405	5054	−1.12	3.44 × 10−5
GE	HGS	Endometriosis	CYP11A1	rs9944175	0.24	2578	9306	−0.872	4.13 × 10−5
GE	ENDO	Estrogen MHT	AKR1C3	rs61856140	0.10	405	5054	−1.47	5.30 × 10−5
GE	ENDO	Endometriosis	CYP11B2	rs28526467	0.43	815	9306	−1.09	6.83 × 10−5
GE	ENDO	OC Use	PRL	rs72836169	0.10	945	10323	−0.827	7.09 × 10−5
BMI-GE	ENDO	Parity	INSR	rs8102954	0.37	778	8284	−2.56	8.35 × 10−6
BMI-GE	All	Parity	IGFBP2	rs869564	0.11	4934	8284	−2.34	1.43 × 10−5
BMI-GE	HGS	OC Use	CYP11B1	rs113759408	0.17	2296	8250	1.49	2.18 × 10−5